ENTRY       D12209                      Drug
NAME        Ozuriftamab (USAN)
FORMULA     C6434H9948N1710O2019S44
EXACT_MASS  144879.6037
MOL_WEIGHT  144968.9365
SEQUENCE    (Heavy chain)
            EVQLVQSGAE VKKPGESLRI SCKGSGYTFT EYTMHWVRQA PGQGLEWMGG INTNNGGTGY
            NQKFKGRVTI SADKSISTAY LQWSSLKASD TAMYYCAHGS LYSYGNSYFD YWGQGTLVTV
            SSASTKGPSV FPLAPSSKST SGGTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ
            SSGLYSLSSV VTVPSSSLGT QTYICNVNHK PSNTKVDKKV EPKSCDKTHT CPPCPAPELL
            GGPSVFLFPP KPKDTLMISR TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ
            YNSTYRVVSV LTVLHQDWLN GKEYKCKVSN KALPAPIEKT ISKAKGQPRE PQVYTLPPSR
            DELTKNQVSL TCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSKLTVDKS
            RWQQGNVFSC SVMHEALHNH YTQKSLSLSP G
            (Light chain)
            AIQLTQSPSS LSASVGDRVT ITCSATSSVS YMHWYLQKPG QSPQLLIYGT SNLASGVPDR
            FSGSGSGTDF TLKISRVEAE DVGVYYCQQR SSYPFTFGQG TKVEIKRTVA APSVFIFPPS
            DEQLKSGTAS VVCLLNNFYP REAKVQWKVD NALQSGNSQE SVTEQDSKDS TYSLSSTLTL
            SKADYEKHKV YACEVTHQGL SSPVTKSFNR GEC
            (Disulfide bridge: H22-H96, H149-H205, H225-L213, H231-H'231, H234-H'234, H266-H326, H372-H430, H'22-H'96, H'149-H'205, H'225-L'213, H'266-H'326, H'372-H'430, L23-L87, L133-L193, L'23-L'87, L'133-L'193)
  TYPE      Peptide
EFFICACY    Antineoplastic
  TYPE      Monoclonal antibody
COMMENT     Treatment of cancers expressing the receptor tyrosine kinase orphan receptor 2 (ROR2) protein
TARGET      ROR2 [HSA:4920] [KO:K05123]
  PATHWAY   hsa04310(4920)  Wnt signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               ROR family
                ROR2
                 D12209  Ozuriftamab (USAN)
DBLINKS     CAS: 2460399-44-2
///
